MHRA’s AI regulatory strategy ensures patient safety and industry innovation into 2030
- MHRA outlines strategic approach to AI regulation, aligning with government white paper.
- Five key strategic principles include safety, transparency, fairness, accountability, and contestability.
- The MHRA has a key role to play in enabling the achievement of the goal for the UK to be a science and technology superpower by 2030
- Benefits of AI adoption include improved efficiencies and earlier access to medical products for UK patients.
- MHRA emphasizes the necessity for regulatory decisions to be evidence-based despite AI integration.
- MHRA is implementing regulatory reforms for AI-driven medical devices, aiming for risk proportionate regulation.
